IOL Chemicals

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE485C01029
  • NSEID: IOLCP
  • BSEID: 524164
INR
184.10
-7.6 (-3.96%)
BSENSE

Nov 20

BSE+NSE Vol: 18.58 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Morepen Labs.
Innova Captab
Bliss GVS Pharma
IOL Chemicals
Orchid Pharma
Senores Pharma.
SPARC
Evonile Pharma
FDC
Guj. Themis Bio.
Supriya Lifesci.
Why is IOL Chemicals & Pharmaceuticals Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.01 times
2
Poor long term growth as Net Sales has grown by an annual rate of 7.43% and Operating profit at 8.08% over the last 5 years
3
With a growth in Net Sales of 5.13%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 4 consecutive quarters
  • ROCE(HY) Highest at 14.08%
  • NET SALES(Q) Highest at Rs 795.03 cr
  • PBDIT(Q) Highest at Rs 109.42 cr.
4
Stock is technically in a Mildly Bullish range
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and OBV
5
With ROE of 11, it has a Very Expensive valuation with a 2.8 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 101.33%, its profits have risen by 82.6% ; the PEG ratio of the company is 0.3
6
Increasing Participation by Institutional Investors
  • Institutional investors have increased their stake by 2.24% over the previous quarter and collectively hold 7.55% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to IOL Chemicals should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is IOL Chemicals for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
IOL Chemicals
101.33%
1.84
55.02%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.43%
EBIT Growth (5y)
8.08%
EBIT to Interest (avg)
11.92
Debt to EBITDA (avg)
0.52
Net Debt to Equity (avg)
0.04
Sales to Capital Employed (avg)
1.15
Tax Ratio
25.38%
Dividend Payout Ratio
23.24%
Pledged Shares
0
Institutional Holding
7.55%
ROCE (avg)
9.81%
ROE (avg)
8.61%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
37
Price to Book Value
2.81
EV to EBIT
19.65
EV to EBITDA
15.10
EV to Capital Employed
2.74
EV to Sales
1.99
PEG Ratio
0.31
Dividend Yield
0.54%
ROCE (Latest)
13.95%
ROE (Latest)
10.99%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

26What is working for the Company
ROCE(HY)

Highest at 14.08%

NET SALES(Q)

Highest at Rs 795.03 cr

PBDIT(Q)

Highest at Rs 109.42 cr.

PBT LESS OI(Q)

Highest at Rs 81.78 cr.

PAT(Q)

Highest at Rs 65.07 cr.

EPS(Q)

Highest at Rs 2.22

-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 126.46 cr

Loading Valuation Snapshot...
Here's what is working for IOL Chemicals
Net Sales - Quarterly
Highest at Rs 795.03 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 109.42 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 81.78 cr has Grown at 52.5% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 53.64 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
At Rs 795.03 cr has Grown at 26.0% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 630.91 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 81.78 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 65.07 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 2.22
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for IOL Chemicals
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 126.46 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents